Cancer Conversations Podcast—Episode #16: The Latest in Prostate Cancer Treatment and Research

Mark Pomerantz, prostate cancer, research, Matthew Freedman, Myles Brown

Mark Pomerantz, MD (left), with Matthew Freedman, MD, and Myles Brown, MD.

Prostate cancer affects 230,000 men each year. Although diagnoses are increasing worldwide, most people die with prostate cancer and not of prostate cancer, according to Mark Pomerantz, MD, a medical oncologist in Dana-Farber’s Lank Center for Genitourinary Oncology.

In this Cancer Conversations podcast episode, Pomerantz discusses genetics, risk factors, and the controversy surrounding the PSA test, a test that can detect levels of prostate-specific antigen in the body. Although PSA testing can help diagnose prostate cancer, it is not universally recommended in the U.S.

“If men are going to die with the disease rather than because of the disease, there are consequences to finding prostate cancer,” explains Pomerantz. “It leads to the psychological impact of having a cancer diagnosis and, more troubling, overtreatment of the disease.”

Pomerantz also discusses the promise of gene therapy, immunotherapy, and clinical trials for men with prostate cancer. “Over time, we are more and more confident that we can safely manage patients without needing immediate cure,” he says.

Listen to the podcast episode below or click “download” to listen later. Subscribe options are also available via iTunes, Google Play, the Stitcher appTuneIn app, and RSS.

The Cancer Conversations series features Q&A-style conversations with Dana-Farber physicians, clinicians, and researchers. Topics include breast cancer research, precision cancer medicine, integrative therapies, cancer genetics, and more. Visit the Cancer Conversations page for more episodes and the Dana-Farber podcast page for more cancer podcast series.

 

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Latest Tweets

Dana-Farber @danafarber
CRISPR, a powerful tool for editing the #DNA instruction manual in animals and humans, is proving a boon to… https://t.co/5WZMiG3WtG
Dana-Farber @danafarber
“This is only the beginning of the era of cancer #immunology,” says Dana-Farber's @OsamaRahma2. “It will only expan… https://t.co/dXrNZf06sJ
Dana-Farber @danafarber
What's the connection between #coloncancer and nuts? Research shows that consuming nuts reduces the risk of colon c… https://t.co/lzw1MzuOZk

Patient and Family Blogs

Patients and families of patients at Dana-Farber often chronicle their own experiences with cancer.

Here are some blogs that you can follow.